Goldman Sachs and affiliates acquire a 6.7% stake in Attovia Therapeutics, signaling confidence in the biological products sector.
| Name | Attovia Therapeutics, Inc. |
|---|---|
| CIK | 0002058707 |
| Tickers | ATTO |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 921510574 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 5103995001 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 1 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Goldman Sachs and affiliates acquire a 6.7% stake in Attovia Therapeutics, signaling confidence in the biological products sector.
Attovia Therapeutics updates stock option details for CEO Fu Tao, clarifying ownership and vesting schedules in the biological products sector.
Attovia Therapeutics updates stock option details for CFO Steven Chan, reflecting important governance practices in the biological products sector.
61 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000905148-26-004977 | 005-95859 | 261563022 | 34 | 36642 | |||
| 2026-11-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000886982-26-000642 | 005-95859 | 261554214 | 34 | 32994 | |||
| 2026-11-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002148983-26-000005 | 005-95859 | 261552844 | 34 | 6650 | |||
| 2026-11-09 | 10-Q | 10-Q | 0001193125-26-453622 | 001-43423 | 261536159 | 34 | 11244517 | 1 | 1 | |
| 2026-11-09 | 8-K | 8-K | 2.02,8.01 | 0001193125-26-453592 | 001-43423 | 261536012 | 34 | 407286 | 1 | 1 |
| 2026-10-08 | 4/A | xslF345X06/form4a-10092026_121054.xml | 0001644888-26-000009 | 6149 | ||||||
| 2026-10-08 | 4/A | xslF345X06/form4a-10082026_111058.xml | 0001654907-26-000009 | 6182 | ||||||
| 2026-10-08 | 3/A | xslF345X06/form3a-10082026_111032.xml | 0001644888-26-000008 | 18347 | ||||||
| 2026-10-08 | 3/A | xslF345X06/form3a-10082026_111047.xml | 0001654907-26-000008 | 13902 | ||||||
| 2026-09-02 | 10-Q | 10-Q | 0001193125-26-380228 | 001-43423 | 261355104 | 34 | 10455793 | 1 | 1 | |
| 2026-09-02 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-380215 | 001-43423 | 261355025 | 34 | 388648 | 1 | 1 |
| 2026-08-28 | 144 | xsl144X01/primary_doc.xml | 0000891836-26-000065 | 001-43423 | 261341768 | 33 | 4788 | |||
| 2026-08-28 | 4/A | FORM 4/A | 0001866174-26-000011 | 69750 | ||||||
| 2026-08-28 | 4/A | FORM 4/A | 0000886982-26-000522 | 80578 | ||||||
| 2026-08-13 | 4 | FORM 4 | 0001866174-26-000009 | 55995 | ||||||
| 2026-08-13 | 4 | FORM 4 | 0000886982-26-000495 | 66811 | ||||||
| 2026-08-12 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003341 | 005-95859 | 261267349 | 34 | 11322 | |||
| 2026-08-11 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001231919-26-000857 | 005-95859 | 261264315 | 34 | 37341 | |||
| 2026-08-10 | 4 | 4 | 0001193125-26-342487 | 11390 | ||||||
| 2026-08-10 | 4 | FORM 4 | 0000905148-26-003548 | 16324 | ||||||
| 2026-08-07 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-092867 | 16085 | ||||||
| 2026-08-07 | 4 | 4 | 0001193125-26-340173 | 10024 | ||||||
| 2026-08-06 | 4 | xslF345X06/form4-08062026_090845.xml | 0001231919-26-000838 | 24507 | ||||||
| 2026-08-06 | 4 | 4 | 0001193125-26-338446 | 5369 | ||||||
| 2026-08-06 | 4 | xslF345X06/form4-08062026_090835.xml | 0001242882-26-000004 | 5613 | ||||||
| 2026-08-06 | 4 | xslF345X06/form4-08062026_090834.xml | 0002141590-26-000008 | 5643 | ||||||
| 2026-08-06 | 4 | xslF345X06/form4-08062026_090833.xml | 0002141655-26-000008 | 5640 | ||||||
| 2026-08-06 | 4 | xslF345X06/form4-08062026_090836.xml | 0002142262-26-000006 | 5636 | ||||||
| 2026-08-06 | 4 | 4 | 0001193125-26-338430 | 001-43423 | 261250381 | 34 | 5714 | |||
| 2026-08-06 | 4 | 4 | 0001193125-26-338420 | 001-43423 | 261250363 | 34 | 5732 | |||
| 2026-08-06 | 8-K | 8-K | 5.03,9.01 | 0001193125-26-338037 | 001-43423 | 261249193 | 34 | 396615 | 1 | 1 |
| 2026-08-06 | S-8 | S-8 | 0001193125-26-336011 | 333-298035 | 261245461 | 33 | 240152 | 1 | 1 | |
| 2026-08-05 | 3 | xslF345X06/form3-08052026_110859.xml | 0002148983-26-000002 | 4182 | ||||||
| 2026-08-05 | 3 | FORM 3 | 0001866174-26-000007 | 7911 | ||||||
| 2026-08-05 | 424B4 | 424B4 | 0001193125-26-334997 | 333-297452 | 261243191 | 33 | 9645768 | |||
| 2026-08-04 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002535 | 333-297452 | 261241079 | 33 | 1737 | ||
| 2026-08-04 | 3 | 3 | 0001193125-26-333469 | 8957 | ||||||
| 2026-08-04 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-090604 | 9622 | ||||||
| 2026-08-04 | 3 | 3 | 0001193125-26-333417 | 11771 | ||||||
| 2026-08-04 | 3 | FORM 3 | 0000905148-26-003465 | 15885 | ||||||
| 2026-08-04 | 3 | 3 | 0001193125-26-333385 | 20777 | ||||||
| 2026-08-04 | 3 | xslF345X06/form3-08042026_110813.xml | 0002141655-26-000006 | 17078 | ||||||
| 2026-08-04 | 3 | xslF345X06/form3-08042026_110839.xml | 0001727703-26-000005 | 10314 | ||||||
| 2026-08-04 | 3 | 3 | 0001193125-26-333377 | 001-43423 | 261240783 | 34 | 22255 | |||
| 2026-08-04 | 3 | xslF345X06/form3-08042026_110811.xml | 0002141590-26-000006 | 17276 | ||||||
| 2026-08-04 | 3 | 3 | 0001193125-26-333373 | 001-43423 | 261240774 | 34 | 26923 | |||
| 2026-08-04 | 3 | xslF345X06/form3-08042026_110836.xml | 0001168404-26-000046 | 13218 | ||||||
| 2026-08-04 | 3 | 3 | 0001193125-26-333371 | 17433 | ||||||
| 2026-08-04 | 3 | xslF345X06/form3-08042026_110804.xml | 0002142262-26-000004 | 15571 | ||||||
| 2026-08-04 | 3 | 3 | 0001193125-26-333362 | 16754 | ||||||
| 2026-08-04 | 3 | FORM 3 | 0000886982-26-000301 | 19009 | ||||||
| 2026-08-04 | 3 | xslF345X06/form3-08042026_100847.xml | 0001231919-26-000827 | 14130 | ||||||
| 2026-08-04 | 3 | 3 | 0001193125-26-333095 | 5823 | ||||||
| 2026-08-04 | CERT | 8A_CERT_ATTO_0002058707.pdf | 0001354457-26-000753 | 001-43423 | 261236953 | 34 | 181196 | |||
| 2026-08-04 | S-1/A | S-1/A | 0001193125-26-331510 | 333-297452 | 261235377 | 33 | 9885481 | 1 | 1 | |
| 2026-07-29 | 8-A12B | 8-A12B | 0001193125-26-323646 | 001-43423 | 261217349 | 34 | 14189 | |||
| 2026-07-29 | S-1/A | S-1/A | 0001193125-26-323618 | 333-297452 | 261217284 | 33 | 11477205 | 1 | 1 | |
| 2026-07-14 | S-1 | S-1 | 0001193125-26-303256 | 333-297452 | 261174611 | 33 | 11860961 | 1 | 1 | |
| 2026-06-05 | DRS/A | filename1.htm | 0001193125-26-259800 | 377-08845 | 261069882 | 33 | 10062763 | |||
| 2026-02-12 | DRS/A | filename1.htm | 0001193125-26-048782 | 377-08845 | 26626482 | 33 | 6787627 | |||
| 2025-12-19 | DRS | filename1.htm | 0001193125-25-326945 | 377-08845 | 251587923 | 33 | 8374165 |
One latest value per concept from companyfacts (148 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 45.71M | 2026-10-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 14,638.33 | 2026-08-05 | S-8 | 2026-08-06 | 0001193125-26-336011 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 14,638.33 | 2026-08-05 | S-8 | 2026-08-06 | 0001193125-26-336011 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 106.00M | 2026-08-05 | S-8 | 2026-08-06 | 0001193125-26-336011 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-05 | S-8 | 2026-08-06 | 0001193125-26-336011 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 33,748.19 | 2026-08-04 | S-1/A | 2026-08-04 | 0001193125-26-331510 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 4.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 539,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 5.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 219,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 1.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -548,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 570.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings | Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings | USD | 2.40M | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 3.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 4.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | Assets | Assets | USD | 411.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 404.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | AvailableForSaleDebtSecuritiesGrossUnrealizedGain | Debt Securities, Available-for-sale, Unrealized Gain | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | AvailableForSaleDebtSecuritiesGrossUnrealizedLoss | Debt Securities, Available-for-sale, Unrealized Loss | USD | 558,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 280.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 115.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 115.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 75.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 8.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 45.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 45.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 5,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -62.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | ConversionOfStockAmountIssued1 | Conversion of Stock, Amount Issued | USD | 258.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 21.52M | 2026-08-06 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostCurrent | Debt Securities, Available-for-sale, Amortized Cost, Current | USD | 281.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 200,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | Depreciation | Depreciation | USD | 488,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-09-02 | 0001193125-26-380228 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 700,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 736,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | DividendsPayableCurrentAndNoncurrent | Dividends Payable | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-09-02 | 0001193125-26-380228 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -4.86 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -4.86 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensation | Employee Benefits and Share-based Compensation | USD | 9.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 2.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 11.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 1.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 157,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | IncreaseDecreaseInDebtSecuritiesTrading | Increase (Decrease) in Debt Securities, Trading | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -1.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 486,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 3.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | InterestReceivable | Interest Receivable | USD | 2.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 5.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 4.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 2.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 1.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 567,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 262,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | Liabilities | Liabilities | USD | 14.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 411.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 11.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | ManufacturingCosts | Manufacturing Costs | USD | 40.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -469,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 306.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -170.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -60.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -61.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -61.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 | Noncash or Part Noncash Acquisition, Fixed Assets Acquired | USD | 6,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | NoncashOrPartNoncashAcquisitionPayablesAssumed1 | Noncash or Part Noncash Acquisition, Payables Assumed | USD | 709,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-09-02 | 0001193125-26-380228 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 5.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 67.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -66.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 1.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 3.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 2.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 1.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 3.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 193,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 586,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -647,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 672,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -86,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 2.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 3.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 276.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 378,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | PreferredStockAccretionOfRedemptionDiscount | Preferred Stock, Accretion of Redemption Discount | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | PreferredStockLiquidationPreferenceValue | Preferred Stock, Liquidation Preference, Value | USD | 255.85M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-09-02 | 0001193125-26-380228 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 8.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 331,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 106.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 78,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-09-02 | 0001193125-26-380228 |
| us-gaap | ProfessionalFees | Professional Fees | USD | 2.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 4.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 3.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 55.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 404,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 115.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 404,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -172.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | Revenues | Revenues | USD | 450,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 3.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 16.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 1.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 4.11 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 1.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 41,556 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 4.17 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 10.58 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 34.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 4.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 9.25 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 34.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 4.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 9.25 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 2.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 2.85 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 16.4 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 397.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 116,040 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 305.34M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 1.63M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 289,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | TemporaryEquityAccretionToRedemptionValue | Temporary Equity, Accretion to Redemption Value | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 258.23M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | TreasuryStockCommonShares | Treasury Stock, Common, Shares | shares | 8,074 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | TreasuryStockCommonValue | Treasury Stock, Common, Value | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 12.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation | Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation | shares | 282,773 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 12.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |
| us-gaap | WriteOffOfDeferredDebtIssuanceCost | Write off of Deferred Debt Issuance Cost | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453622 |